Lonza and Allevi pool resources for 3D bioprinting 07-Jan-2020 By Ben Hargreaves Lonza signs a collaboration deal with Allevi to offer researchers the tools needed for ‘plug-and-play’ bioprinting for drug research.
Charles River closes $380m HemaCare cell therapy takeover 07-Jan-2020 By Nick Taylor Charles River Laboratories closes $380m takeover of cell therapy specialist HemaCare to expand in fast-growing sector.
NEWS IN BRIEF Aurobindo recalls depression treatment over mislabeled strength 06-Jan-2020 By Ben Hargreaves Aurobindo announces a voluntary recall of mirtazapine tablets after bottles of tablets marked as 7.5mg were found to potentially contain 15mg tablets.
ClinOne enters EU with first office in the UK 06-Jan-2020 By Vassia Barba ClinOne looks to further support its clinical trial partners in the European Union by opening its first office in the region, located in London, UK.
FDA greenlights first generics of blood thinner 06-Jan-2020 By Vassia Barba Mylan and Micro Labs receive US FDA approval for two generic versions of Pfizer and BMS’ Eliquis, marking the first generic approvals of direct oral anticoagulants.
Cyclo taps Worldwide Clinical Trials to run rare disease, Alzheimer's studies 06-Jan-2020 By Nick Taylor Cyclo Therapeutics signs master services agreement with Worldwide Clinical Trials for studies in two indications.
Tools for doctors key to increasing clinical trial diversity, say experts 06-Jan-2020 By Nick Taylor Sponsors should ‘continually’ think about providing tools to help healthcare professionals discuss clinical trials with women and older people.
FDA rejects ViiV HIV drug on CMC grounds 06-Jan-2020 By Nick Taylor GSK and Pfizer joint venture suffers regulatory rejection after US FDA finds fault with filing.
